ArticleAntibiotics (Basel, Switzerland)2025
Epidemiological Situation of Antibiotic-Resistant Microorganisms Identified in Patients Hospitalised at the University Teaching Hospital in Bialystok, Poland, in the 2020-2023 Period.
Article in Antibiotics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Drug-Resistant Gram-Positive Cocci as Etiological Factors of Cardiac Implantable Electronic Device Infections-Data from the EXTRACT Registry.Antibiotics (Basel, Switzerland) · 2026Article
- Risk assessment of selected bacterial infections acquired in intensive care units in Poland in the years 2019-2023-analysis with the application of the standardized infection ratio.Frontiers in cellular and infection microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionAntimicrobial resistance constitutes one of the key challenges to public health. It is a particularly serious problem in the context of hospital-acquired infections (HAIs). By causing infections that are difficult to treat, multiple-drug-resistant bacteria in the hospital environment often require the use of toxic and costly drugs and prolonged hospital stays, and they result in long-term health consequences for patients, including a high risk of death. This study aimed to assess the epidemiological situation of antibiotic-resistant microorganisms in patients hospitalised at the University Teaching Hospital in Bialystok, Poland, between 2020 and 2023.
methodsData from epidemiological reports covering 15 alert pathogens, including MRSA, VRE, KPC (+), and ESBL (+), were analysed. Their prevalence was assessed in three groups of wards: intensive care, surgical, and non-surgical. Infection and microbiological testing rates were referenced to the number of hospitalisations and patient-days.
resultsA total of 6066 cases of infections caused by resistant microorganisms were identified. The most frequently isolated pathogen was
conclusionsThe rise in infections caused by antibiotic-resistant bacteria requires a high level of microbiological surveillance to be maintained, especially in intensive care units, and preventive measures at hospital admission to be strengthened.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.